This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Reports
Country profiles
Clinical Excellence
Cardiology
Respiratory
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Gastroenterology
Adalimumab biosimilar Imraldi launched in European Union
Read more
Coeliac disease diagnosis rises to 30% – but still missing half a million
Read more
EC approves early dose optimisation of Simponi for ulcerative colitis patients
Read more
Peanut allergy drug passes clinical trial
Read more
Biosimilar infliximab comparable to reference product and adalimumab in real-world study
Read more
Therapy for the prevention of recurrence of Clostridium difficile infection is launched in the UK
Read more
Bowel Cancer UK identifies critical research gaps
Read more
Adalimumab biosimilar approved in Europe for the treatment of multiple chronic inflammatory diseases
Read more
One-year results for biosimilar infliximab switching study in Crohn’s disease
Read more
Symptom improvement in moderately to severely active Crohn’s disease with ustekinumab
Read more
Guideline for the management of nut allergy helps to define diagnostic pathways, including the role of specific IgE testing
Read more
Positive CHMP opinion for adalimumab biosimilar
Read more
Eluxadoline receives final approval from NICE for the treatment of IBS with diarrhoea
Read more
Biosimilar adalimumab and infliximab accepted for regulatory review by the EMA
Read more
Treating paediatric short bowel syndrome
Read more
Use of extended-pulsed regimen with fidaxomicin more effective than standard vancomycin in CDI
Read more
NICE recommends Stelara for moderate to severe Crohn’s disease
Read more
Page 9 of 12
« First
«
...
7
8
9
10
11
...
»
Last »
Popular articles
Does cancer screening actually reduce all-cause mortality?
25 September, 2023
Stress and high workload confirmed as main reasons staff leave NHS
25 September, 2023
Ruxolitinib approved by NICE for treatment of polycythaemia vera
25 September, 2023
×
Search for: